HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Marketing in Brief: Guerlain

This article was originally published in The Rose Sheet

Executive Summary

Guerlain: Adding Odelys stabilizing serum to sensitive skin product mix in May. Designed for use as a "calming, preparatory serum that neutralizes reactive tendencies of sensitive skin," the stabilizing serum allows skin "to tolerate even active skin care products" like anti-aging creams, high SPF products and eye makeup, Guerlain said. The serum includes oubaku tree extract, which is said to heal skin, reduce inflammation and calm "reactive tendencies"and linden tree extract to "balance skin" and restore "normalcy." Available in May, a 1 oz. bottle will cost $54. Guerlain is also unveiling Odelys Perfect Care No. 3 Super-Rich in May. Formulated to "protect, soothe and balance dry or dehydrated skin," Super-Rich includes liquorice extract that "soothes and decongests the skin" and vitamin E that "fights skin's aging." A 1.7 oz. jar will cost $49...

Latest Headlines
See All
UsernamePublicRestriction

Register

RS002515

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel